Muscle-invasive Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Muscle-invasive Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC) [Phase 2]
A Phase 2 trial evaluating autogene cevumeran added to nivolumab versus nivolumab alone in high-risk muscle-invasive urothelial carcinoma; t…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
This clinical trial evaluates nivolumab in Japanese participants with muscle-invasive urothelial carcinoma. The study is currently active bu…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma [Phase 1, Phase 2]
Early-phase clinical trial evaluating neoadjuvant dose-dense MVAC with durvalumab and tremelimumab in muscle-invasive urothelial carcinoma (…
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection [Phase 3]
Phase 3 trial comparing atezolizumab to observation as adjuvant therapy in high-risk muscle-invasive urothelial carcinoma after surgery; stu…